Ledger.Open graph →
SEC Form D · filed October 5, 2022

Switch Therapeutics Inc

Offering
$35.0M
Sold
$19.9M
Exemption
Rule 506(b)
Industry
Other
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Kevin Zhang · South San Francisco, CADirectorDeepshikha Datta · South San Francisco, CAExec · DirectorSi-Ping Han · South San Francisco, CAExecDylan Morris · South San Francisco, CADirectorAlicia Irurzun-Lafitte · South San Francisco, CADirectorAaron Ginn · Miami, FLDirectorChristopher T. Mcguire · New York, NYExec · DirectorGarrett Johnson · Miami, FLDirectorBradley Whiting · BELFAIR, WADirectorJake Stenziano · KNOXVILLE, TNExecMatthew P. Jacobson · SOUTH SAN FRANCISCO, CADirectorThilo H. Schroeder · SOUTH SAN FRANCISCO, CADirectorWalter H. Moos · SOUTH SAN FRANCISCO, CADirectorJames H. Evangelista · SOUTH SAN FRANCISCO, CAExecDavid J. Earp · SOUTH SAN FRANCISCO, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗